Protein engineering of cell surfaces is a potentially powerful technol
ogy through which the surface protein composition of cells can be mani
pulated without gene transfer, This technology exploits the fact that
proteins that are anchored by glycoinositol phospholipids (GPIs), when
purified and added to cells in vitro, incorporate into their surface
membranes and are fully functional, By substituting 3'-mRNA end sequen
ce of naturally GPI-anchored proteins (i.e., a sequence that contains
the signals that direct GPI anchoring) for endogenous 3'-mRNA end sequ
ence, virtually any protein of interest can be expressed as a GPI-anch
ored derivative, The GPI-anchored product then can be purified from tr
anfectants and the purified protein used to ''paint'' any target cell,
Such protein engineering or ''painting'' of the cell surface offers s
everal advantages over conventional gene transfer, Among these advanta
ges are that 1) GPI-anchored proteins can be painted onto cells that a
re difficult to transfect, 2) cells can be altered immediately without
previous culturing, 3) the amount of protein added to the surface can
be precisely controlled, and 4) multiple GPI-anchored proteins can be
sequentially or concurrently inserted into the same cells, Emerging a
pplications for the technology include its nse for the analysis of com
plex cell-surface interactions, the engineering of antigen presenting
cells, the development of cancer vaccines, and possibly the protection
against graft rejection.